IKZF1 and precursor B-cell acute lymphoblastic leukemia: Moreover, IKZF1 deletion events, accompanied by CREBBP deletion or mutation, were common in relapsed pediatric B-ALL patients, which could correlate with the selective pressure of chemotherapeutic drugs on tumor cells (8).